N-terminal-pro-brain natriuretic peptide elevations in the course of septic and non-septic shock reflect systolic left ventricular dysfunction assessed by transpulmonary thermodilution
IJC Metabolic and Endocrine , Volume 10 p. 30- 35
Background: The cardiac correlates, if any, of N-terminal probrain natriuretic peptide (NT-proBNP) levels in septic and non-septic shock patients remain controversial. Methods: In the 38 septic and 22 non-septic shock patients in the transpulmonary thermodilution arm of a previous 2-center randomized controlled trial comparing pulmonary artery catheterization with transpulmonary thermodilution, serial (daily for 3 days) and paired measurements (n = 145) were obtained of NT-proBNP and transpulmonary dilution variables as global ejection fraction (GEF), left ventricular preload-recruitable stroke work (PRSW) and diastolic compliance. Results: Elevated NT-proBNP inversely related to low GEF and PRSW in pooled data (r = -0.45, P < 0.001). The 72 h course of NT-proBNP was inversely associated with PRSW, independent of age, gender, creatinine, norepinephrine treatment and diastolic compliance, without differences between septic and non-septic shock. Over the 72 h study period, NT-proBNP levels were higher in 28 day non-survivors than survivors, independent of type of shock and disease severity. Conclusions: In septic and non-septic shock, NT-proBNP elevations reflect systolic left ventricular dysfunction and are associated with a poor outcome. They may help recognition of cardiac dysfunction in shock and its management when invasive hemodynamic monitoring is not yet instituted.
|Cardiac function, Natriuretic peptides, Renal function, Sepsis, Shock, Transpulmonary thermodilution|
|IJC Metabolic and Endocrine|
|Organisation||Department of Intensive Care|
Groeneveld, A.B.J, & Trof, R.J. (2016). N-terminal-pro-brain natriuretic peptide elevations in the course of septic and non-septic shock reflect systolic left ventricular dysfunction assessed by transpulmonary thermodilution. IJC Metabolic and Endocrine, 10, 30–35. doi:10.1016/j.ijcme.2016.01.002